JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
Rush University Medical Center
Chicago, Estados UnidosPublicaciones en colaboración con investigadores/as de Rush University Medical Center (2)
2020
-
Endothelin-1-mediated drug resistance in EGFR-mutant non-small cell lung carcinoma
Cancer Research, Vol. 80, Núm. 19, pp. 4224-4232
2019
-
CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC
Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452